Recap: Global Blood Therapeutics Q1 Earnings

Global Blood Therapeutics GBT reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Global Blood Therapeutics beat estimated earnings by 3.08%, reporting an EPS of $-1.26 versus an estimate of $-1.3.

Revenue was up $16.12 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.23 which was followed by a 4.93% increase in the share price the next day.

Here's a look at Global Blood Therapeutics's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -1.13 -1.11 -1.19 -1.01
EPS Actual -1.36 -1.13 -1.12 -1.21
Revenue Estimate 55.44M 53.70M 43.84M 43.00M
Revenue Actual 56.10M 52.05M 47.55M 39.04M

To track all earnings releases for Global Blood Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!